Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

APOMORPHINE HYDROCHLORIDE

APOMORPHINE HYDROCHLORIDE

Standard Dose
30MG/3ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview APOMORPHINE HYDROCHLORIDE is listed in Drugs@FDA under application 212025 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient APOMORPHINE HYDROCHLORIDE Form and strength INJECTABLE;SUBCUTANEOUS - 30MG/3ML (10MG/ML) Sponsor TP ANDA HOLDINGS Submission history Latest submission status date: 2022-02-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview APOMORPHINE HYDROCHLORIDE is listed in Drugs@FDA under application 212025 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient APOMORPHINE HYDROCHLORIDE Form and strength INJECTABLE;SUBCUTANEOUS - 30MG/3ML (10MG/ML) Sponsor TP ANDA HOLDINGS Submission history Latest submission status date: 2022-02-23 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.